TIMP2 and acute kidney injury: These observations suggest that new AKI biomarkers, including TIMP-2, can detect renal structural damage independently from functional changes shown by serum creatinine elevation and that a combination of kidney functional and damage markers enable stratification of patients with AKI at risk for poor outcomes [43].